In exchange for a few drops of blood or saliva, patients are now able to obtain information based upon variations in their DNA sequences that will one day help them benefit from the prescribing of more effective tailored drugs and avoid some of the more serious side effects.
"That is the tantalizing promise of personalized medicine," says Dr. Amalia M Issa, the Director of the Program in Personalized Medicine and Targeted Therapeutics, and Professor and Chair of the Department of Health Policy and Public Health.
What is Personalized Medicine? One Size Does Not Fit All
Medications that help one patient are often ineffective or even harmful for another person. Emerging technologies are making it possible to tailor treatments to improve health outcomes. Delivering personalized medicine involves integrating genetic data with clinical data and family histories in order to more coherently customize therapeutics to patients.
Personalized Medicine Today
Personalized medicine is being applied in cancer treatments, and also increasingly for cardiovascular, neurological and psychiatric disorders to name a few areas.
The increasing integration of personalized medicine applications into clinical practice and health systems raises important questions about how personalized medicine can best help patients without increasing costs and improve health outcomes.
Leading the Way
With such rapid developments, it is important to understand how we can develop effective strategies for introducing these new technologies into real-world health care delivery settings.
Dr. Issa, an internationally recognized expert in the field of personalized medicine, and her team at the Program in Personalized and Targeted Therapeutics are conducting research aimed at understanding how personalized medicine applications will be translated from bench to bedside to community and integrated effectively into clinical practice and health care delivery.
“The key question that drives our research,” says Dr. Issa, “is what is needed for personalized medicine to be well-integrated into clinical practice and effectively incorporated into health care delivery and health systems?”
In weeks to come, Dr. Issa and her team will be sharing developments from the world of personalized medicine.
Save the Date: Making the Connections: Personalized Medicine - From Promise to Policy and Public Health
Tuesday, April 17, 2012, from 5:30 to 7:30 p.m. at University of the Sciences
Join us as a panel of renowned speakers provides an engaging update of the field of personalized medicine and explores the field from public health and health policy perspectives as well as business and economic aspects.